Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.

Saved in:
Bibliographic Details
Title: Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health.
Authors: Lee CH; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Bui TPN; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands., Petitfils C; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Jian C; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Wong GC; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Puel A; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Le Roy T; Nutrition and obesities : systemic approaches, Nutriomics, Sorbonne Université, Inserm, Paris, France., Bellais S; BIOASTER, Lyon, France., Ben Abdallah B; BIOASTER, Lyon, France., Nehlich M; BIOASTER, Lyon, France., Leicht T; BIOASTER, Lyon, France., Jia M; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Hoyles L; Department of Biosciences, School of Science & Technology, Nottingham Trent University, Nottingham, UK., Federici M; IRCCS Neuromed, Pozzilli, Italy.; Department of Systems Medicine, Center for Atherosclerosis, University of Rome Tor Vergata, Rome, Italy., Fernández-Real JM; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Madrid, Spain.; Department of Diabetes, Endocrinology and Nutrition, Dr. Josep Trueta University Hospital, Girona, Spain., Burcelin R; UMR 1297 INSERM, Team INCOMM, Rangueil Hospital, Toulouse, France., Dumas ME; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; European Genomic Institute for Diabetes, U1283 INSERM, UMR8199 CNRS, Institut Pasteur de Lille, Lille University Hospital, University of Lille, Lille, France., Delzenne NM; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium., Clavel T; Functional Microbiome Research Group, Institute of Medical Microbiology, University Hospital of RWTH Aachen, Aachen, Germany., Boeren S; Biochemistry, Wageningen University, Wageningen, Netherlands., Troise AD; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy., Scaloni A; Proteomics, Metabolomics & Mass Spectrometry Laboratory, ISPAAM, National Research Council, Portici, Italy., Muccioli GG; Bioanalysis and Pharmacology of Bioactive Lipids Research Group (BPBL), Louvain Drug Research Institute (LDRI), UCLouvain, Université catholique de Louvain, Brussels, Belgium., De Vos WM; Departments of Experimental Vascular Medicine, Amsterdam University Medical Centres (AMC), Amsterdam, Netherlands.; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Laboratory of Microbiology, Wageningen University, Wageningen, Netherlands., Van Hul M; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium., Cani PD; Louvain Drug Research Institute (LDRI), Metabolism and Nutrition research group (MNUT), UCLouvain, Université catholique de Louvain, Brussels, Belgium patrice.cani@uclouvain.be Matthias.Vanhul@uclouvain.be.; Walloon Excellence in LifeSciences and BIOtechnology (WELBIO) department, WELResearch Institute, Wavre, Belgium.; Section of Biomolecular Medicine, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Institute of Experimental and Clinical Research (IREC), UCLouvain, Université catholique de Louvain, Brussels, Belgium.
Source: Gut [Gut] 2026 Jun 09; Vol. 75 (7), pp. 1338-1352. Date of Electronic Publication: 2026 Jun 09.
Publication Type: Journal Article
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-3288
DOI:10.1136/gutjnl-2025-336617